LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
MLCO
Melco Resorts & Entertainment Limited
MLCO has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MLCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Stable | |
| Weak |
MLCO's profitability is currently strong, and its revenue and cash flow are stable, but its balance sheet is weak.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MLCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7x | $4.18 | — |
| Cheap | 9.5x | $5.68 | +36% |
| Fair | 30x | $17.78 | +325% |
| Expensive | 50x | $30.05 | +619% |
Historical ranges are pointers, not guarantees.
MLCO's PE is in its cheap range at 7.0x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MLCO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect MLCO's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MLCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.60 | +362% |
| Q1 2026 | $0.58 | +314% |
| Q4 2025 | $0.46 | +360% |
| Q3 2025 | $0.26 | +$0.53 |
| Q2 2025 | $0.13 | +$0.50 |
| Q1 2025 | $0.14 | +$0.62 |
| Q4 2024 | $0.10 | +$0.84 |
| Q3 2024 | -$0.27 | +$0.71 |
MLCO has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MLCO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MLCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3B | -5.6% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | +8.6% |
| Q3 2025 | $1.3B | +11% |
| Q2 2025 | $1.3B | +15% |
| Q1 2025 | $1.2B | +11% |
| Q4 2024 | $1.2B | +8.9% |
| Q3 2024 | $1.2B | +16% |
MLCO's revenue is growing: $1.3B last quarter, down 5.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 10% | +0.9 points |
| Q1 2026 | 13% | +1.6 points |
| Q4 2025 | 11% | +3.2 points |
| Q3 2025 | 14% | +2.3 points |
| Q2 2025 | 9.4% | -1.3 points |
| Q1 2025 | 12% | +0.5 points |
| Q4 2024 | 8.1% | +17 points |
| Q3 2024 | 12% | +2.5 points |
MLCO has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has the edge over MLCO on cash flow, with more consistent year-over-year improvement.
MLCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
MLCO's free cash flow was $0 over the past year, against $0 the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MLCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 5.4x | High |
| Q1 2026 | 5.0x | High |
| Q4 2025 | 5.2x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 6.1x | High |
| Q1 2025 | 6.2x | High |
| Q4 2024 | 6.3x | High |
| Q3 2024 | 7.5x | High |
MLCO's net debt is about 5.4 years of its operating earnings (EBITDA), down from 6.1 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MLCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 25.9 | Neutral |
MLCO's weekly RSI is 37 (neutral) and its Stochastic is 26 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MLCO PE vs Consumer Cyclical Sector
| Metric | MLCO | Sector median | Relative |
|---|---|---|---|
| PE | 7x | 18x | 61% below |
| PE % | 2 | 47 | 45 pts below |
MLCO is trading at 7.0x earnings, a 61% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MLCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.21 | 0.7% below |
| 20 week MA | $4.90 | 15% below |
| 50 week MA | $5.64 | 26% below |
| 100 week MA | $6.38 | 34% below |
| 200 week MA | $7.74 | 46% below |
MLCO is in a downtrend: it's below all five of its weekly moving averages, and 46% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MLCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.4 | $18.6 | -24% |
| 2021 | $18.6 | $10.4 | -44% |
| 2022 | $10.4 | $11.2 | +7% |
| 2023 | $11.2 | $8.87 | -21% |
| 2024 | $8.87 | $5.88 | -34% |
| 2025 | $5.88 | $8.01 | +36% |
| 2026 YTD | $8.01 | $4.18 | -48% |
MLCO has the edge over LCID on returns for 2026, with the stronger performance.